Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 194

1.

Melanocytic tumors of uncertain malignant potential: results of a tutorial held at the XXIX Symposium of the International Society of Dermatopathology in Graz, October 2008.

Cerroni L, Barnhill R, Elder D, Gottlieb G, Heenan P, Kutzner H, LeBoit PE, Mihm M Jr, Rosai J, Kerl H.

Am J Surg Pathol. 2010 Mar;34(3):314-26. doi: 10.1097/PAS.0b013e3181cf7fa0.

PMID:
20118771
2.

Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus.

Zembowicz A, Carney JA, Mihm MC.

Am J Surg Pathol. 2004 Jan;28(1):31-40. Erratum in: Am J Surg Pathol. 2004 May;28(5):following table of contents.

PMID:
14707861
3.

Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome.

Barnhill RL, Argenyi ZB, From L, Glass LF, Maize JC, Mihm MC Jr, Rabkin MS, Ronan SG, White WL, Piepkorn M.

Hum Pathol. 1999 May;30(5):513-20.

PMID:
10333219
4.

Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus").

Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto V, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ.

Am J Surg Pathol. 2008 Jan;32(1):36-44.

PMID:
18162768
5.

Spitz nevi and atypical Spitz nevi/tumors: a histologic and immunohistochemical analysis.

Kapur P, Selim MA, Roy LC, Yegappan M, Weinberg AG, Hoang MP.

Mod Pathol. 2005 Feb;18(2):197-204.

6.

Evaluation of DNA ploidy and degree of DNA abnormality in benign and malignant melanocytic lesions of the skin using video imaging.

Pilch H, Günzel S, Schäffer U, Tanner B, Heine M.

Cancer. 2000 Mar 15;88(6):1370-7.

PMID:
10717619
7.

Melanoma and melanocytic tumors of uncertain malignant potential in children, adolescents and young adults--the Stanford experience 1995-2008.

Berk DR, LaBuz E, Dadras SS, Johnson DL, Swetter SM.

Pediatr Dermatol. 2010 May-Jun;27(3):244-54. doi: 10.1111/j.1525-1470.2009.01078.x. Epub 2010 Apr 9.

PMID:
20403119
8.

The dermal-based borderline melanocytic tumor: a categorical approach.

Magro CM, Crowson AN, Mihm MC Jr, Gupta K, Walker MJ, Solomon G.

J Am Acad Dermatol. 2010 Mar;62(3):469-79. doi: 10.1016/j.jaad.2009.06.042.

PMID:
20159313
9.

Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.

Zembowicz A, Knoepp SM, Bei T, Stergiopoulos S, Eng C, Mihm MC, Stratakis CA.

Am J Surg Pathol. 2007 Nov;31(11):1764-75.

PMID:
18059235
10.
11.

The atypical Spitz tumor of uncertain biologic potential: a series of 67 patients from a single institution.

Ludgate MW, Fullen DR, Lee J, Lowe L, Bradford C, Geiger J, Schwartz J, Johnson TM.

Cancer. 2009 Feb 1;115(3):631-41. doi: 10.1002/cncr.24047.

12.

Sentinel lymph node biopsy in histologically ambiguous melanocytic tumors with spitzoid features (so-called atypical spitzoid tumors).

Murali R, Sharma RN, Thompson JF, Stretch JR, Lee CS, McCarthy SW, Scolyer RA.

Ann Surg Oncol. 2008 Jan;15(1):302-9. Epub 2007 Nov 14.

PMID:
18000712
13.

Cutaneous melanoma and atypical Spitz tumors in childhood.

Barnhill RL, Flotte TJ, Fleischli M, Perez-Atayde A.

Cancer. 1995 Nov 15;76(10):1833-45.

14.

Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.

Su LD, Fullen DR, Sondak VK, Johnson TM, Lowe L.

Cancer. 2003 Jan 15;97(2):499-507.

15.
16.

Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up.

Mandal RV, Murali R, Lundquist KF, Ragsdale BD, Heenan P, McCarthy SW, Mihm MC Jr, Scolyer RA, Zembowicz A.

Am J Surg Pathol. 2009 Dec;33(12):1778-82. doi: 10.1097/PAS.0b013e3181b94f3c.

PMID:
19773637
17.

Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?

Kaleem Z, Lind AC, Humphrey PA, Sueper RH, Swanson PE, Ritter JH, Wick MR.

Mod Pathol. 2000 Mar;13(3):217-22.

18.

The role of lymphatic mapping and sentinel node biopsy in the management of atypical and anomalous melanocytic lesions.

Cochran AJ, Binder S, Morton DL.

J Cutan Pathol. 2010 Apr;37 Suppl 1:54-9. doi: 10.1111/j.1600-0560.2010.01509.x.

PMID:
20482676
19.

Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.

Nasr MR, El-Zammar O.

Am J Dermatopathol. 2008 Apr;30(2):117-22. doi: 10.1097/DAD.0b013e3181624054.

PMID:
18360113
20.

Sentinel lymph node biopsy in patients with diagnostically controversial spitzoid melanocytic tumors.

Lohmann CM, Coit DG, Brady MS, Berwick M, Busam KJ.

Am J Surg Pathol. 2002 Jan;26(1):47-55.

PMID:
11756768

Supplemental Content

Support Center